Berwick Donald M 4

What Happened Donald M. Berwick, a director of NRC Health (NRC), was granted 7,697 restricted stock units (RSUs) on 2026-06-23. The Form 4 reports 7,697 shares acquired at $0.00 (award code A); the filing shows $0 as the acquisition cost because this is an equity grant. A footnote clarifies the award represents annual equity compensation equal to $150,000, converted into RSUs based on the closing price the day before the issuer's 2026 annual meeting.

Key Details

• Transaction date: 2026-06-23; Form 4 filed 2026-06-25 (filed within the standard 2-business-day window).
• Reported on-form price: $0.00 per share (award); footnote value: $150,000 total grant (converted to 7,697 RSUs).
• Vesting: Award will vest and become exercisable on the date of the issuer's 2027 annual stockholder meeting, subject to forfeiture and termination provisions.
• Plan: Granted under the Issuer's 2025 Omnibus Incentive Plan.
• Shares owned after transaction: not specified in the provided filing.
• Transaction code: A (award/grant).

Context This was a compensation award (RSUs), not an open-market purchase or sale. RSUs typically convert to shares when they vest and are generally taxable as ordinary income at vesting; they do not directly signal insider buying or selling intent. The filing appears timely and includes a footnote explaining the $150,000 grant conversion.